Larimar Therapeutics (LRMR) PT Lowered to $5 at Baird
Tweet
Share
E-mailGet Alerts LRMR Hot Sheet
Price: $3.82 -4.74%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
Baird analyst Joel Beatty lowered the price target on Larimar Therapeutics (NASDAQ: LRMR) to $5.00 (from $7.00) while maintaining a Outperform rating.
You May Also Be Interested In
- RBC Capital Downgrades Bapcor Ltd. (BAP:AU) to Underperform
- Piper Sandler Upgrades Akamai Technologies (AKAM) to Overweight
- Assembly Biosciences (ASMB) PT Lowered to $45 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
